ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company
Sitemap | Login/Register | Contact | Careers


NSN 6505-01-509-4493, 6505015094493
DACLIZUMAB

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 015094493
Codification Country
United States
Item Name Code
INC 77777
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-509-4493
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-509-4493

Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-509-4493

National Stock Number (NSN) 6505-01-509-4493, or NIIN 015094493, (daclizumab) was assigned June 23, 2003 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There is only one manufacturer part number associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

This NSN is assigned to Item Name Code (INC) 77777. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505015094493 does not contain precious metals.

This information was last updated on .

Technical Characteristics

SPECIAL FEATURES
(FEAT) IMMUNOSUPPRESIVE HUMANIZED MONOCLONAL ANTIBODY PRODUCED BY RECOMINANT DNA TECHNOLOGY THAT BINDS SPECIFICALLY TO THE ALPHA SUBUNIT OF THE HUMAN HIGH-AFFINITY INTERLUKIN RECEPTOR THAT IS EXPRESSED ON THE SURFACE OF ACTIVATED LYMPHOCYTES; SUPPLIED AS CLEAR STERILE, COLORLESS CONCENTRATE FOR FURTHER DILUTION AND INTERVENOUS ADMINISTRATION IN SINGLE-USE GLASS VIALS; EACH VIAL CONTAINS 25 MG OF DACLIZUMAB IN 5ML OF SOLUTION; STORE BETWEEN 2-8 DEG C; DO NOT SHAKE OR FREEZE
SPECIAL FEATURES
(FEAT) OIMMUNOSUPPRESIVE HUMANIZED MONOCLONAL ANTIBODY PRODUCED BY RECOMINANT DNA TECHNOLOGY THAT BINDS SPECIFICALLY TO THE ALPHA SUBUNIT OF THE HUMAN HIGH-AFFINITY INTERLUKIN RECEPTOR THAT IS EXPRESSED ON THE SURFACE OF ACTIVATED LYMPHOCYTES; SUPPLIED AS CLEAR STERILE, COLORLESS CONCENTRATE FOR FURTHER DILUTION AND INTERVENOUS ADMINISTRATION IN SINGLE-USE GLASS VIALS; EACH VIAL CONTAINS 25 MG OF DACLIZUMAB IN 5ML OF SOLUTION; STORE BETWEEN 2-8 DEG C; DO NOT SHAKE OR FREEZE

Manufacturer Part Numbers

ZENAPAX25MGMLIV

RNCC
3
RNVC
2
6505015094493

015094493

015094493


Related Inventory



 
Top